Filtered By:
Condition: Atrial Fibrillation
Drug: Aspirin
Countries: Germany Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Stenosis Length and Degree Interact With the Risk of Cerebrovascular Events Related to Internal Carotid Artery Stenosis
Conclusion: We found a statistically insignificant tendency for the ultrasound-measured length of sICAS<70% to be longer than that of sICAS≥70%. Moreover, the ultrasound-measured length of sICAS<90% was significantly longer than that of sICAS 90%. Among patients with sICAS≥70%, the degree and length of stenosis were inversely correlated. Larger studies are needed before a clinical implication can be drawn from these results. Introduction Internal carotid artery stenosis (ICAS) causes around one-fifth of ischemic cerebrovascular stroke and has the highest risk of early stroke recurrence...
Source: Frontiers in Neurology - April 8, 2019 Category: Neurology Source Type: research

ARRIVE, ASCEND and the Future of Aspirin
“An aspirin a day keeps the doctor away,” an age-old adage revised to support stroke prevention, may no longer be relevant in light of new data presented at the European Society of Cardiology (ESC) Scientific Congress 2018 in Munich, Germany. Of course we have known for some time—and data cont inue to support us—that aspirin is highly effective in secondary prevention of cardiovascular disease (ie, in patients who have already had an adverse vascular event).
Source: ConsultantLive - September 6, 2018 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news